Product Description: AP30663 is a KCa2 channel inhibitor that can be used for the study of atrial fibrillation[1].
Applications: Neuroscience-Neuromodulation
Formula: C20H18F3N5O
References: [1]Holst A G, Tomcsányi J, Vestbjerg B, et al. Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial[J]. Nature Medicine, 2023: 1-6.
Molecular Weight: 401.39
Research Area: Cardiovascular Disease
Solubility: 10 mM in DMSO
Target: Potassium Channel